EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

CNS manifestations in acute and chronic graft-versus-host disease

Nicolas Lambert iD, Florence Forte, Majdouline El Moussaoui, Justine Monseur, Nicole Raus, Alexey Polushin, David Michonneau, Carl Shultz, William J Hogan, Aitana Balaguer-Roselló, Sara Gil-Perotín iD, Jan Brijs und 20 weitere

Brain · 03.04.2025 · 148 (4) · 1122-1133

DOI: 10.1093/brain/awae340 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Brain, online erschienen am 23.10.2024. Verfasst von Nicolas Lambert und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Hospital of Liège, 4000 Liège, Belgium. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Central Nervous System Diseases. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the growing evidence supporting the existence of CNS involvement in acute and chronic graft-versus-host disease (CNS-GvHD), the characteristics and course of the disease are still largely unknown. In this multicentre retrospective study, we analysed the clinical, biological, radiological and histopathological characteristics, as well as the clinical course of 66 patients diagnosed with possible CNS-GvHD (pCNS-GvHD), selected by predetermined diagnostic criteria. Results were then contrasted depending on whether pCNS-GvHD onset occurred before or after Day 100 following allogeneic haematopoietic stem cell transplantation (allo-HSCT). The median time between allo-HSCT and pCNS-GvHD onset was 149 days (interquartile range25–75 48–321), and pCNS-GvHD onset occurred before Day 100 following transplantation in 44% of patients. The most frequent findings at presentation were cognitive impairment (41%), paresis (21%), altered consciousness (20%), sensory impairment (18%) and headache (15%). Clinical presentation did not significantly differ between patients with pCNS-GvHD occurring before or after Day 100 following transplantation. Brain MRI found abnormalities compatible with the clinical picture in 57% of patients, while CT detected abnormalities in only 7%. Seven patients had documented spinal cord MRI abnormalities, all of them with pCNS-GvHD occurring after Day 100 following transplantation. In the CSF, the white blood cell count was increased in 56% of the population (median 18 cells/μl). Histopathological analyses were performed on 12 specimens and were suggestive of pCNS-GvHD in 10. All compatible specimens showed parenchymal and perivascular infiltration by CD3+ and CD163+ cells. Immunosuppressive therapy was prescribed in 97% of patients, achieving complete clinical response in 27%, partial improvement in 47% and stable disease in 6%. Response to immunosuppressive therapy did not differ significantly between patients with pCNS-GvHD occurring before or after Day 100 following transplantation. Clinical relapse was observed in 31% of patients who initially responded to treatment. One-year overall survival following pCNS-GvHD onset was 41%. Onset before Day 100 following haematopoietic stem cell transplantation [hazard ratio with 95% confidence interval: 2.1 (1.0–4.5); P = 0.041] and altered consciousness at initial presentation [3.0 (1.3–6.7); P = 0.0077] were associated with a reduced 1-year overall survival probability. Among surviving patients, 61% had neurological sequelae. This study supports that immune-mediated CNS manifestations may occur following allo-HSCT. These can be associated with both acute and chronic GvHD and carry a grim prognosis. The clinical presentation as well as the radiological and biological findings appear variable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationCentral Nervous System DiseasesHumansMaleFemaleAdultMiddle AgedRetrospective StudiesChronic DiseaseAcute DiseaseYoung AdultAgedMagnetic Resonance Imaging

Stichwörter der Autor:innen

GvHDbrain lesionsencephalitisimmune-mediatedneurological complicationsspinal cord lesions

Autor:innen und Institutionen

  • Department of Neurology, University Hospital of Liège, 4000 Liège, Belgium.
  • Department of Infectious diseases and General Internal Medicine, University Hospital of Liège, 4000 Liège, Belgium.
  • Biostatistics and Research Methods center (B-STAT), Department of Public Health, University of Liège, 4000 Liège, Belgium.
  • Department of Hematology Marcel-Bérard secteur 1G, Centre hospitalier Lyon sud, 69310 Pierre-Bénite, France.
  • Department of Chemotherapy and Stem Cell Transplantation for Cancer and Autoimmune Diseases, First Pavlov State Medical University of St. Peterburg, 197022 Saint Petersburg, Russia.
  • Hematology and Transplantation Unit, Saint Louis Hospital, Université Paris Cité, 75010 Paris, France.

ORCID-Profile: Nicolas Lambert, Sara Gil-Perotín, Yves Chalandon, Jonathan D Santoro, Sophie Servais

Zitieren

APA

Lambert, N., Forte, F., El Moussaoui, M., Monseur, J., Raus, N., Polushin, A., Michonneau, D., Shultz, C., Hogan, W. J., Balaguer-Roselló, A., Gil-Perotín, S., Brijs, J., Chauvet, P., Gavriilaki, M., Carre, M., Dulamea, A. O., Chalandon, Y., Salmenniemi, U., Duminuco, A., …, & CNS-GvHD Study Group (2025). CNS manifestations in acute and chronic graft-versus-host disease. Brain, 148(4), 1122-1133. https://doi.org/10.1093/brain/awae340

Vancouver

Lambert N, Forte F, El Moussaoui M, Monseur J, Raus N, Polushin A, et al. CNS manifestations in acute and chronic graft-versus-host disease. Brain. 2025;148(4):1122-1133. doi:10.1093/brain/awae340

BibTeX
@article{Lambert2025,
  author = {Lambert, Nicolas and Forte, Florence and El Moussaoui, Majdouline and Monseur, Justine and Raus, Nicole and Polushin, Alexey and Michonneau, David and Shultz, Carl and Hogan, William J and Balaguer-Roselló, Aitana and Gil-Perotín, Sara and Brijs, Jan and Chauvet, Paul and Gavriilaki, Maria and Carre, Martin and Dulamea, Adriana Octaviana and Chalandon, Yves and Salmenniemi, Urpu and Duminuco, Andrea and Ram, Ron and García-Cadenas, Irene and Porto, Gaetana and Nguyen, Stéphanie and Smallbone, Portia and González-Vicent, Marta and Santoro, Jonathan D and Willems, Evelyne and Baron, Frédéric and Servais, Sophie and Beguin, Yves and Maquet, Pierre and CNS-GvHD Study Group, CNS-GvHD Study Group},
  title = {CNS manifestations in acute and chronic graft-versus-host disease},
  journal = {Brain},
  year = {2025},
  volume = {148},
  number = {4},
  pages = {1122--1133},
  doi = {10.1093/brain/awae340}
}
Kostenlos starten →